Search
-
CAR T-Cell Therapy Proves Effective in First Trial in Patients with Resistant Multiple Myeloma
A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber Cancer Institute, and Roswell Park Comprehensive Cancer Center report in a new study.
… Wednesday, September 28, 2022 A therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impressive results in its first clinical trial in patients with multiple myeloma, researchers at Memorial Sloan Kettering Cancer Center (MSK), Dana-Farber
-
News
Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division.
… Friday, October 18, 2013 Summary Memorial Sloan Kettering cell biologist Emily Foley discusses her research, which is focused on improving the understanding of cell division. Emily Foley, a laboratory investigator in the Sloan Kettering Institute Cell Biology Program , studies the molecular mechanisms
-
News
Gerstner Sloan Kettering student Elizabeth Wasmuth has been awarded the Chairman’s Prize for her paper published in Nature in 2014, on which she was the first author.
… Monday, August 3, 2015 Gerstner Sloan Kettering student Elizabeth Wasmuth has been awarded the Chairman’s Prize for her first-author paper Structure of an Rrp6-RNA exosome complex bound to poly (A) RNA , published in Nature in 2014. Elizabeth is currently doing her research in the laboratory of Christopher
-
News
The American College of Surgeons recently designated Memorial Sloan Kettering Cancer Center (MSK) the first-ever Children’s Surgery Verification (CSV) Quality Improvement Program Level I Specialty Children’s Surgery Center in Oncology. The distinction recognizes MSK as a highly specialized hospital providing exceptional surgical care that matches children’s needs with optimal pediatric resources.
… Tuesday, May 16, 2023 The American College of Surgeons recently designated Memorial Sloan Kettering Cancer Center (MSK) the first-ever Children’s Surgery Verification (CSV) Quality Improvement Program Level I Specialty Children’s Surgery Center in Oncology. The distinction recognizes MSK as a highly
-
News
Memorial Sloan Kettering Cancer Center’s (MSK) Deputy Chief Nursing Officer, Kevin P. Browne, DNP, RN, CNS, CCRN, was named the recipient of the 2021 Firefighter Thomas Phelan Memorial Award by the Irish American Building Society (IABS).
… Thursday, September 30, 2021 Memorial Sloan Kettering Cancer Center’s (MSK) Deputy Chief Nursing Officer, Kevin P. Browne, DNP, RN, CNS, CCRN, was named the recipient of the 2021 Firefighter Thomas Phelan Memorial Award by the Irish American Building Society (IABS). The award, which recognizes courageous
-
News
An analysis of patients with Lynch syndrome treated at MSK finds that immunotherapy drugs called checkpoint inhibitors may prevent serious tumors from forming.
… Monday, October 16, 2023 Immunotherapy drugs called checkpoint inhibitors may prevent serious tumors from forming in some people with an increased risk of cancer due to a condition called Lynch syndrome , according to new research published October 16, 2023, in Nature Medicine by Memorial Sloan Kettering
-
News
MSK scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement.
… Thursday, November 6, 2014 Summary For the first time, Memorial Sloan Kettering scientists have created a mouse model that replicates a subtype of non-small cell lung cancer caused by a chromosomal rearrangement — a type of mutation that is common in cancers but thus far has been very difficult to study
-
News
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.
… Wednesday, December 4, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: Jun Mao Awarded $2.4 Million from the Patient-Centered Outcomes Research Institute to Improve the Quality of Acupuncture and Massage for Cancer Patients Jun Mao Jun Mao, MD
-
News
… Friday, March 20, 2026 Student Research Six students make the transition from students to scientists as they begin their dissertation research. Eric Alonzo Eric Alonzo — Elucidating the role of PLZF in gd T cell development Our lab has recently shown that the Promyelocytic Leukemia Zinc Finger (PLZF)
-
News
American Thyroid Association guidelines endorse close observation as a treatment option for many small papillary thyroid tumors rather than surgery. MSK endocrinologist Michael Tuttle MD discusses why monitoring such cancers is a viable approach.
… Thursday, August 31, 2017 VIDEO | 02:27 Active Monitoring of Papillary Thyroid Cancer American Thyroid Association guidelines endorse close observation as a treatment option for many small papillary thyroid tumors rather than surgery. MSK endocrinologist Michael Tuttle MD discusses why monitoring such